Adriana Rauseo Acevedo

Medicine & Life Sciences

1. Histoplasmosis 100%
2. SARS Virus 91%
3. Severe Acute Respiratory Syndrome 62%
4. Coronavirus 61%
5. Infections 50%
6. Candida 46%
7. Itraconazole 40%
8. Mortality 32%
9. TAK-652 29%
10. Coronavirus Infections 26%
11. HIV 25%
12. Vaccines 25%
13. Randomized Controlled Trials 24%
14. Immunity 24%
15. Blastomycosis 22%
16. Invasive Fungal Infections 22%
17. Therapeutics 22%
18. Coccidioidomycosis 21%
19. Invasive Candidiasis 21%
20. Abatacept 21%
21. Lactobacillus rhamnosus 21%
22. Addison Disease 20%
23. Hydroxychloroquine 20%
24. Smokeless Tobacco 19%
25. Mineralocorticoids 19%
26. Voriconazole 19%
27. Cell-Free Nucleic Acids 18%
28. Germinal Center 17%
29. Mycoses 17%
30. Infliximab 17%
31. Antifungal Agents 17%
32. Agglutination 17%
33. Latex 17%
34. Glycyrrhiza 17%
35. Fluconazole 17%
36. Complement Activation 17%
37. Chloroquine 16%
38. Cardiologists 16%
39. Microbiota 16%
40. Plasma Cells 16%
41. Adult Respiratory Distress Syndrome 16%
42. Bone Marrow Cells 16%
43. Propensity Score 16%
44. Mitochondrial DNA 15%
45. Azoles 15%
46. Hospital Mortality 15%
47. Paralysis 14%
48. Communicable Diseases 14%
49. Transplant Recipients 13%
50. Placebos 13%